STING1 and neoplasm: Two intraperitoneal injections of the STING agonist DMXAA (12.5 mg kg−1 body weight) in the second week post-tumour implantation significantly but comparably decreased tumour sizes in Sel1LLyz2 versus Sel1Lf/f mice (Extended Data Fig. 9a,b).